The Epstein–Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB

Ähnliche Einträge

• The Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 Engages the Tumor Necrosis Factor Receptor-Associated Proteins TRADD and Receptor-Interacting Protein (RIP) but Does Not Induce Apoptosis or Require RIP for NF-κB Activation
  von: Izumi, Kenneth M., et al.
  Veröffentlicht: (1999)
• Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
  von: Kaye, K M, et al.
  Veröffentlicht: (1993)
• Role of the TRAF Binding Site and NF-κB Activation in Epstein-Barr Virus Latent Membrane Protein 1-Induced Cell Gene Expression
  von: Devergne, Odile, et al.
  Veröffentlicht: (1998)
• Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-κB in the absence of NF-κB essential modifier residues 133–224 or 373–419
  von: Boehm, Daniela, et al.
  Veröffentlicht: (2010)
• The Epstein–Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation
  von: Izumi, Kenneth M., et al.
  Veröffentlicht: (1997)